VIA
ARNA

Vident Investment Advisory’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Vident Investment Advisory’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-74,881
Closed -$6.96M – 1362
2021
Q4 		$6.96M Buy
74,881
+3,355
+5% +$221K 0.18% 128
2021
Q3 		$4.26M Buy
+71,526
New +$4.22M 0.13% 159
2020
Q3 		– Sell
-30,281
Closed -$1.91M – 951
2020
Q2 		$1.91M Sell
30,281
-4,868
-14% -$268K 0.1% 207
2020
Q1 		$1.48M Sell
35,149
-2,491
-7% -$114K 0.1% 268
2019
Q4 		$1.71M Buy
+37,640
New +$1.78M 0.11% 296

Vident Investment Advisory's ARNA Position: Q1 2022 in Review

Vident Investment Advisory sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 74,881 shares — an estimated $6.96M sold.

Vident Investment Advisory first reported a position in ARNA in Q4 2019 and held it in 5 quarters. The position peaked at $6.96M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Vident Investment Advisory reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Vident Investment Advisory sold 74,881 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $6.96M.
  • Vident Investment Advisory first reported a position in Arena Pharmaceuticals Inc in Q4 2019 and held it in 5 quarters.
  • Vident Investment Advisory's Arena Pharmaceuticals Inc position peaked at $6.96M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Vident Investment Advisory's 13F filing for Q1 2022, filed 16 May 2022.